美諾華(603538.SH)擬發行5.2億元可轉債 初始轉股價37.47元/股
格隆匯1月11日丨美諾華(603538.SH)公佈,公司公開發行5.20億元可轉債,每張面值為人民幣100元,共計520萬張,52萬手,按面值發行。可轉債簡稱為“美諾轉債”,債券代碼為“113618”。初始轉股價格為37.47元/股,募集資金擬用於高端製劑項目及補充流動資金。
本次可轉債發行原股東優先配售日與網上申購日同為2021年1月14日(T日),網上申購時間為T日9:30-11:30,13:00-15:00,不再安排網下發行。原股東及社會公眾投資者在2021年1月14日(T日)參與優先配售後餘額部分的網上申購時無需繳付申購資金。
網上路演時間:2021年1月13日(週三)10:00-12:00
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.